Duane Reade partners with MoneyGram International to wire funds to Haiti relief
NEW YORK Duane Reade has partnered with MoneyGram International to enable Duane Reade customers to wire funds to Haiti free of charge.
“We offer our condolences to all New Yorkers whose friends or family members have been affected by this devastating event,” stated John Lederer, chairman and CEO of Duane Reade and board member of the Duane Reade Charitable Foundation. “We hope that through our partnership with MoneyGram we can offer some small relief to those in need of assistance and make it a little bit easier for New Yorkers to extend their financial support directly to recipients in the country.”
In addition to its partnership with MoneyGram, the Duane Reade Charitable Foundation is supporting the American Red Cross International Relief Fund through a direct cash donation in the amount of $10,000 and through a company-wide employee match program up to a maximum of an additional $10,000 donation.
The free direct wire transfer program runs through Jan. 24, with the possibility of extending the program thereafter. Duane Reade currentlyoffers MoneyGram services at approximately 180 of its more than 250 locations in the metropolitan New York region.
For a list of Duane Reade locations that offer MoneyGram services visit www.duanereade.com. In addition, the MoneyGram site at www.moneygram.com offers an updated list of wire transfer locations that are confirmed to be operational in Haiti.
As previously announced by MoneyGram, anyone who wishes to support recovery in Haiti by donation to the American Red Cross can also do so free of charge from any MoneyGram Express Payment agent location. Use the Red Cross code 3886 to send a donation.
NCR survey provides insight for retailers regarding consumers’ use of social media
DULUTH, Ga. Shoppers are looking for enhanced personalization and more choices in how they interact with retailers through social media, according to a recent survey conducted by global technology company NCR.
The NCR survey polled more than 400,000 consumers regarding their experiences with social media and how retailers can better serve their needs.
“Social media is an exciting way for retailers to engage customers and build communities of interest around their brand,” said Sundeep Kapur, director, strategic marketing, NCR Corp. “The survey results demonstrate that retailers who present a holistic understanding of their customers and deliver more personalized, relevant offers through social media can open new revenue channels and see a greater return on investment through social media.”
In response to this, NCR, through its Aptra eMarketing initiative, optimizes the way businesses communicate with their customers and clients by controlling the relevance, personalization and timing of marketing messages via a specific choice of medium.
NCR Aptra eMarketing was presented at the National Retail Federation tradeshow earlier this week.
Researchers find key to chemotherapy resistance in lung cancer patients
SCOTTSDALE, Ariz. Researchers in Arizona have found a way to predict which patients might be resistant to first-line chemotherapy in the treatment of small-cell lung cancer, calling their findings a breakthrough in the treatment of lung cancer.
Of the 32,000 cases of SCLC patients diagnosed each year in the United States, between 15% and 30% are resistant to the treatment, a condition known as chemoresistance.
The researchers, at TGen Clinical Research Services at Scottsdale Healthcare looked at tumor microRNAs, molecules that regulate gene expression in the process of making proteins and directing the structure and function of cells, a process that usually prevents cancer, finding three that appeared to predict which patients would be chemoresistant. The researchers hope the findings will go toward developing better clinical drug trials.
“For patients with small-cell lung cancer, there are really only about two chemotherapy options,” researcher Glen Weiss said in a statement. “We need to be more precise with our treatments and identify who is going to be resistant up front in order to design better clinical trials that will identify effective therapies for these at-risk patients.”
The researchers plan to present their findings at a joint conference of the American Association for Cancer Research and the International Association for the Study of Lung Cancer in San Diego.